{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:18:56Z","timestamp":1785406736903,"version":"3.56.0"},"reference-count":22,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"crossref","award":["121C387"],"award-info":[{"award-number":["121C387"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]},{"award":["121C387"],"award-info":[{"award-number":["121C387"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Istanbul Atlas University"},{"id":[{"id":"https:\/\/ror.org\/02jqzm779","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Objectives: Noninvasive prenatal testing relies on the analysis of total cell-free DNA (cfDNA) in maternal plasma, where fetal-derived DNA constitutes only a minor fraction. This study aimed to preliminarily compare a modified TPY cfDNA extraction protocol with two commercial extraction kits for the downstream detection of Y-chromosome-specific markers in pregnancies carrying male fetuses. Methods: Plasma samples were obtained from 52 singleton pregnancies between 10 and 30 weeks of gestation with male fetal sex confirmed by ultrasonography. Total cfDNA was extracted from aliquots of the same maternal plasma samples using the modified TPY protocol, the QIAamp DSP Virus Kit, and the MagMAX\u2122 Cell-Free DNA Isolation Kit. Quantitative real-time PCR was performed for the Y-chromosome-specific markers SRY and DYS14. At the same time, GLO was used as a reference marker to reflect the total cfDNA background. Extraction performance was assessed primarily using total cfDNA concentration and Ct values obtained from amplification of fetal-specific Y-chromosome markers. Results: Total cfDNA concentrations varied among the extraction methods, with the commercial kits yielding higher total cfDNA concentrations than the modified TPY protocol. In contrast, the TPY protocol yielded slightly lower mean Ct values for SRY and DYS14 than the commercial kits. SRY and DYS14 amplification was detected in 90.4% and 94.2% of samples, respectively. However, these Ct differences should be interpreted cautiously because fetal fraction, maternal DNA contamination, extraction recovery, and fragment size distribution were not directly measured. Conclusions: The modified TPY protocol showed preliminary technical feasibility for extracting total cfDNA from maternal plasma and enabling downstream amplification of Y-chromosome-specific markers in male pregnancies. Nevertheless, the observed lower Ct values do not establish selective fetal DNA enrichment, reduced maternal DNA contamination, or clinical superiority over commercial methods. Further analytical validation using standardized fetal fraction measurement, recovery efficiency testing, fragment size analysis, fetal-to-maternal DNA ratio assessment, and larger cohorts including both male and female pregnancies is required before broader clinical applicability can be determined.<\/jats:p>","DOI":"10.3390\/diagnostics16121849","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:00:48Z","timestamp":1781535648000},"page":"1849","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary Comparison of a Modified cfDNA Extraction Protocol for Y-Chromosome Marker Detection in Maternal Plasma"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-6892","authenticated-orcid":false,"given":"Tugba","family":"Elgun","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Biruni University, Istanbul 34015, T\u00fcrkiye"},{"name":"Biruni University Research Center (B@MER), Biruni University, Istanbul 34015, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin Musteri","family":"Oltulu","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Biruni University, Istanbul 34015, T\u00fcrkiye"},{"name":"Biruni University Research Center (B@MER), Biruni University, Istanbul 34015, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-5613","authenticated-orcid":false,"given":"Burcin Erkal","family":"Cam","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Y\u0131ld\u0131z Technical University, Istanbul 34349, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4172-4748","authenticated-orcid":false,"given":"Halil Ibrahim","family":"Arslan","sequence":"additional","affiliation":[{"name":"Biruni University Research Center (B@MER), Biruni University, Istanbul 34015, T\u00fcrkiye"},{"name":"Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Y\u0131ld\u0131z Technical University, Istanbul 34349, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-1876","authenticated-orcid":false,"given":"Fulya Ozkal","family":"Molla","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Biruni University, Istanbul 34015, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Ata","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Marmara University, Istanbul 34722, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiye","family":"Gok Yurttas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34403, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1056\/NEJMra1705345","article-title":"Sequencing of circulating cell-free DNA during pregnancy","volume":"379","author":"Bianchi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pd.5620","article-title":"Fetal fraction and noninvasive prenatal testing: What clinicians need to know","volume":"40","author":"Hui","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gim.2022.03.019","article-title":"ACMG Professional Practice and Guidelines Committee. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","volume":"24","author":"Rose","year":"2022","journal-title":"Genet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"244.e1","DOI":"10.1016\/j.ajog.2023.12.008","article-title":"Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: A nationwide retrospective cohort study of 56,110 pregnant women","volume":"231","author":"Becking","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12967-020-02671-8","article-title":"Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four semi-automated extraction methods: Impact in two clinical applications, chimerism quantification and noninvasive prenatal diagnosis","volume":"19","author":"Pedini","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcp.2018.12.006","article-title":"Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood","volume":"43","author":"Jain","year":"2019","journal-title":"Mol. Cell. Probes"},{"key":"ref_7","first-page":"93","article-title":"Prenatal screening service for fetal RHD genotyping to guide prophylaxis: The two-year experience of the Friuli Venezia Giulia region in Italy","volume":"21","author":"Londero","year":"2023","journal-title":"Blood Transfus."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1042\/CS20210380","article-title":"Non-invasive prenatal diagnosis: How analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders","volume":"136","author":"Hanson","year":"2022","journal-title":"Clin. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tracli.2023.04.004","article-title":"Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh-negative women in Turkey","volume":"30","author":"Elgun","year":"2023","journal-title":"Transfus. Clin. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e33131","DOI":"10.1016\/j.heliyon.2024.e33131","article-title":"Early fetal sex determination using a fluorescent DNA nanosensing platform capable of simultaneous detection of SRY and DYS14 sequences in cell-free fetal DNA","volume":"10","author":"Mohebbi","year":"2024","journal-title":"Heliyon"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26254","DOI":"10.1038\/s41598-025-09757-7","article-title":"Evaluation of the prenatal diagnostic value of non-invasive prenatal testing for the detection of rare fetal autosomal trisomies: A single center study of 83,842 cases","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-025-01588-5","article-title":"Universal noninvasive prenatal diagnosis for monogenic disorders using cell-free plasma DNA","volume":"18","author":"Zhang","year":"2025","journal-title":"Genome Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yang, S., He, Y., Lv, J., Li, R., and Fu, X. (2025). The evolution of cell-free fetal DNA testing: Expanded non-invasive prenatal testing and clinical applications. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1522680"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e41563","DOI":"10.1016\/j.heliyon.2024.e41563","article-title":"Analysis of fetal fraction in non-invasive prenatal testing using low-depth whole-genome sequencing","volume":"11","author":"Xie","year":"2025","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gim.2011.8","article-title":"Noninvasive fetal sex determination in maternal plasma: A prospective feasibility study","volume":"14","author":"Galindo","year":"2012","journal-title":"Genet. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis","volume":"62","author":"Lo","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.gim.0000241904.32039.6f","article-title":"Quantity versus quality: Optimal methods for cell-free DNA isolation from plasma of pregnant women","volume":"8","author":"Jorgez","year":"2006","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10815-019-01425-w","article-title":"Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma","volume":"36","author":"Akbariqomi","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_19","first-page":"100038","article-title":"Successful early fetal sex determination using cell-free fetal DNA isolated from maternal capillary blood: A pilot study","volume":"3","author":"Kazachkova","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8889-1_1","article-title":"Traditional prenatal diagnosis: Past to present","volume":"1885","author":"Levy","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_21","first-page":"85","article-title":"Evaluation of a modified DNA extraction method for isolation of cell-free fetal DNA from maternal serum","volume":"7","author":"Keshavarz","year":"2015","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/gm422","article-title":"Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing","volume":"5","author":"Chen","year":"2013","journal-title":"Genome Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1849\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:23:28Z","timestamp":1781843008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16121849"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16121849","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}